Article summary
This week's edition of IP weekly highlights includes various Brexit developments including the European Commission’s consultation on enforcement and protection of IP rights in third countries and the CITMA and CIPA’s response to the Ministry of Justice’s consultation on the UK courts and tribunals’ departure from retained EU case law. It also includes analysis of the General Court’s ruling in Glaxo Group v EUIPO in which it upheld the rejection of Glaxo’s application to register the colour purple for pharmaceutical preparations and inhalers for treating asthma and Advocate General Hogan’s opinion in BY, that submitting copyright protected material to court as evidence in civil proceedings does not constitute an act of communication to the public and, therefore, is not an infringement of the rights holder’s exclusive rights.
To continue reading this news article, as well as thousands of others like it, sign in with LexisNexis or register for a free trial